ABBV-142

· AbbVie

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ABBV-142, covering 2026-02-17 to 2026-04-09. Get the full timeline:

Most recent: Clinical Trial Update: Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis [Phase 2]

See pricing